| Term 
 | Definition 
 
        | Nonselective direct acting sympathomimetic 
 alpha>beta
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nonselective direct acting sympathomimetic 
 beta>alpha
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Direct acting sympathomimetic alpha-1 receptor agonist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Direct acting sympathomimetic alpha-2 antagonist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Direct acting sympathomimetic beta1=beta2 agonist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Direct acting sympathomimetic beta1>beta2
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Direct acting sympathomimetic 
 Selective beta2 agonist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Direct acting sympathomimetic 
 Selective beta2 agonist
 |  | 
        |  | 
        
        | Term 
 
        | Indirect acting sympathomimetics |  | Definition 
 
        | Amphetamine 
 Cocaine
 
 Dopamine
 
 Ephedrine
 
 Tyramine
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha-adrenergic antagonist Non-selective
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha-adrendergic antagonist 
 alpha1>>alpha2
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta-adrenergic antagonist 
 beta1>beta2
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta-adrenergic antagonist 
 beta1>beta2
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mixed alpha/beta antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mixed alpha/beta antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta3 nonselective agonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Direct acting sympatholytic 
 alpha2 agonist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Calcium channel antagonist at cardiac channels |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Calcium channel antagonist at peripheral muscle |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Reversible cholinesterase inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Reversible cholinesterase inhibitor, peripherally restricted |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Irreversible cholinesterase inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Irreversible cholinesterase inhibitor, pesticide |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cholinesterase reactivator |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic antagonist (ocular) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic antagonist (inhaled) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | OVERagonist of nicotinic receptor, causes paralysis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhibits acetylcholine release |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Non-depolarizing nicotinic receptor antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Non-depolarizing nicotinic receptor antagonist |  | 
        |  |